Advisory Board and Editors COVID-19
Pragyan Acharya
Dr. Pragyan Acharya is an Associate Professor in the Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India. The major interests of her laboratory is in understand immune dysregulation in liver diseases and understanding the interaction of the immune system in tissue injury and infection. Towards this, she combines studies on clinical samples, in vitro cultures and animal models of liver disease. She is specifically studying non-alcoholic fatty liver disease (NAFLD) and acute-on-chronic liver failure (ACLF) using proteomics and cell biological approaches. Work carried out in her laboratory has led to the identification of the importance of the CD177+ neutrophil sub-population in ACLF and its association with patient outcomes.
Mohd Adnan
Prof. Dr. Mohd Adnan is a Principal Investigator and Head of Academic Committee at Department of Biology, College of Science, University of Ha'il, Saudi Arabia. He did his PhD from University of Central Lancashire, UK; Master’s and Bachelor’s degree from Bangalore University, India; Post Graduate Diploma in Bioinformatics from SJAIT, India. He has more than 14 years of research, teaching and administrative experience. In his professional capacity, he has received various travel, observership and research grants as a Principal Investigator from various prestigious organizations.
He has successfully published 250+ publications in internationally recognized peer reviewed reputed journals, several book chapters for internationally renowned publishers and presented many papers and posters in various conferences/workshops globally. He has published widely in the field of phytomedicine, biofilms, drug discovery, natural products, nutraceuticals and functional foods with specialization in plant-based antibiofilm and anticancer agents, microbial biosurfactants, biofilms in food industry and medical settings, probiotics and cancer biology, novel biomolecules for/as health and antimicrobial agents.
He has reviewed 400+ manuscripts for 70+ internationally recognized peer-reviewed JCR journals and grant reviewer for many prestigious universities and organisations. In addition, he is a member of SFAM, UK and ESCMID, Switzerland and an Elected Member of Royal Society of Biology, UK. He also currently holds different editorial positions (Associate, Academic, Guest and Review Editor) in various esteemed journals and has edited 500+ manuscripts.
Carlos Albuquerque
Carlos Manuel de Sousa Albuquerque is a Professor at the Escola Superior de Saúde of the Instituto Politécnico de Viseu (ESSV).
His other roles at ESSV include; Coordinating Professor, Pro-President of the IPV, Vice-Coordinator of the Health and Education Sciences Research Unit, President and Vice-President of the Pedagogical Council, and Vice-President of the Technical-Scientific Council.
Dr. de Sousa Albuquerque is also President of the General Assembly of the Scientific Association for Health Promotion and Education, of which he is Co-Founder. He is Vice-President of the National Board of the Catholic Association of Nurses and Health Professionals-ACEPS, and an integrated doctoral researcher at the Health Sciences Research Unit: Nursing (UNICISA-E) at the Coimbra College of Nursing.
Dr. de Sousa Alburquerque's research interests include, Determinants of Health and Disease, Psychomotor Rehabilitation Processes, Epidemiology of Chronic Diseases, and Child and Adolescent Psychology.
In addition to these roles, Dr. de Sousa Albuquerque is also a collaborating researcher at the Center for Research in Child Studies at the University of Minho and Center for Studies in Education and Innovation at the Polytechnic Institute of Viseu.
Dr. de Sousa Albuquerque received his Integrated Master's degree in Medicine, from the Faculty of Medicine of Coimbra (2014), his Postgraduate degree in Medical Hydrology, from the Faculty of Medicine of Porto (2017), his degree in Psychology, from the University of Trás-os-Montes and Alto Douro (2009), and his PhD in Psychology, specializing in Psychological Development and Intervention, from the University of Extremadura (2004). In addition, he also received his Master's degree in Health Sociopsychology, from the Instituto Superior Miguel Torga (1999), and his degree in Nursing, Rehabilitation specialty, from the Coimbra Nursing School (1988).
He is the author of numerous scientific articles published in National and International Scientific Journals, also collaborating on the team of editors of recognized journals in the field of health sciences and social sciences. He is a scientific referee expert for several journals: Millenium-Journal of Education, Technologies, and Health; Reference Magazine; Serving Magazine; Interação em Psicologia Magazine; and Health Magazine of the University of Guarulhos - Brazil.
Claudio Andaloro
Dr. Claudio Andaloro is MD at Department of Surgery, Otolaryngology Unit, Latisana-Palmanova Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy. His research interests focus on rhinology, laryngology, pediatric otolaryngology and sleep medicine.
José Alberto Benítez-Andrades
Jose Alberto Benítez-Andrades received the B.S. degree in Computer Engineering and PhD in Production Engineering and Computing from the University of León, Spain, in 2010 and 2017 respectively. He is Associate Professor at the University of León. His research is related to the application of artificial intelligence techniques, knowledge engineering and social network analysis applied mainly to problems related to the field of health. He has more than 40 publications indexed in JCR, 30 communications in international conferences, is associate editor of the journal BMC Medical Informatics and Decision Making, has organized several international conferences since 2018 and is an evaluator of international projects for the government of Spain and Peru.
Chengming Fan
Prf. Chengming Fan is a Surgeon in the Department of Cardiovascular Surgery at Central South University. HIs current basic research interests include treatment of ischemic heart disease with human induced pluripotent stem cells (hiPSC)-related strategy and with preclinical animal models.
B. Brett Finlay
The Peter Wall Distinguished Professor of the University of British Colombia. Recipient of several awards including the E.W.R. Steacie Prize, the CSM Fisher Scientific Award, an MRC Scientist, five Howard Hughes International Research Scholar Awards, a CIHR Distinguished Investigator, BC Biotech Innovation Award, the Michael Smith Health Research Prize, the IDSA Squibb award, the Jacob Biely Prize. Cofounder of Inimex Pharmaceuticals, Inc., and Director of the SARS Accelerated Vaccine Initiative
Maria Elena Flacco
Prof. Maria Elena Flacco is Associate Professor of Epidemiology, Medical Statistics and Public Health at the University of Ferrara, Italy. Her areas of research include epidemiology, public and occupational health, and biostatistics and methods.
Marta Giovanetti
My research focuses on investigating the patterns of gene flow in pathogen populations, focusing in phylogenetics and phylogeography as tools to recreate and understand the determinants of viral outbreaks and how this information can be translated into public policy recommendations. More specifically, my research focuses on recent arboviral outbreaks in Latin America (Zika, Chikungunya, Dengue and Yellow fever viruses and more recently SARS-CoV-2 in Brazil, Italy and South Africa), combining genetic, spatial and ecological information. I am interested in the epidemiology and ecology of viruses in natural populations. My research involves developing and applying techniques to integrate virus genetic data with traditional clinical and demographic data.
Fanglin Guan
Prof. Fanglin Guan is Dean at Xi'an Jiaotong University. He is engaged in the integrated biological research of complex diseases, including tumor microenvironment and novel immunotherapeutic modalities, and research on the mechanisms and medical applications related to tumor cell vaccines, especially for the exploration of the mechanism of determining the biomarkers of complex diseases.
Altijana Hromić-Jahjefendić
Dr. Altijana Hromić-Jahjefendić is an associate professor at the Genetics and Bioengineering Department at International University of Sarajevo, Bosnia and Herzegovina. She obtained her bachelor's degree in chemistry and master's degree in Biochemistry and Molecular Biomedicine at Graz University of Technology, Austria. After that she worked for Austrian Center of Industrial Biotechnology and continued to pursue her PhD degree in Biochemistry and Molecular Biomedicine with the focus on Structural biology. Since 2018. she works as professor at International University of Sarajevo at the Genetics and Bioengineering Department. She authored many scientific publications with international colleagues in the field of COVID-19 and cancer research.
Jorge Kalil
Jorge Kalil is Professor of Clinical Immunology and Allergy and Director of the Laboratory of Immunology at the Heart Institute (InCor), School of Medicine, University of São Paulo (FMUSP), Brazil. He is Adjunct Professor at the George Washington University, DC, USA, and at the Case Westen University, Cleveland. He represents Latin America in the scientific advisory board of the International Institute of Genetic Engineering and Biotechnology (ICGEB), an UNO Institution since 2013 and a member of the Brazilian Academy of Sciences since 1995. Since 2001, he coordinates iii-Institute for Investigative Immunology, a National Institute linked to the Ministry of Science and Technology, in Brazil. In addition, he co-chairs the Federation of Clinical Immunology Societies - FOCIS Center of Excellence in São Paulo and member of the Council of the USP Pasteur Institute’s board since 2018. He is member of the DSMB/NIH for analyses of phase 3 clinical trials of vaccines anti COVID supported by the US government and board member of COVAX, a WHO/GAVI/CEPI initiative to selecting and buying COVID vaccines to distribute to the world. Kalil graduated in Medicine in Brazil (1977), has a Master’s degree in Immunology and Immunogenetics and is Doctor of Science in Human Biology. He is currently developing vaccines against COVID-19 Streptococcus, HIV, Dengue and Zika in advanced scientific stage.